Gene polymorphism of endothelial NO-synthase, angiotensin-converting enzyme and receptors of angiotensin II type 1 in patients with coronary artery disease and type II diabetes.
DOI:
https://doi.org/10.26641/2307-0404.2013.4.20370Ключові слова:
diabetes mellitus, coronary artery disease, gene polymorphismАнотація
Purpose: to study the clinical manifestations of coronary artery disease (CAD) in patients with diabetes mellitus (DM) II type and the possible association of mutations in the genes of endothelial NO-synthase (eNOS), angiotensin-converting enzyme (ACE) and receptor of angiotensin II type 1 (AT2R1) with the development of type II diabetes in these patients. Materials and methods. The study involved 318 patients with CAD, of whom 54 (17,0%) patients had type II DM and 264 (83,0%) patients -without diabetes. Study of allelic polymorphism of T-786S of eNOS gene promoter, insertion-deletion (I/D) polymorphism of ACE gene and polymorphism A1166S of AT2R1 gene was performed by polymerase chain reaction. Results. In patients with CAD and DM type II such risk factors as hypertension, obesity, family history with early onset of cardiovascular disease were significantly more common; CAD manifestation occurs at a younger age, myocardial ischemia more often has silent nature. In the presence of type II DM, coronary artery lesions were of diffuse and multivessel character, other vascular pools are often involved in the atherosclerotic process. An independent association of type II diabetes with hypertension, obesity, and CC genotype of eNOS gene T-786S polymorphism was identified in patients with CAD. Negative independent influence of ACE gene I/D polymorphism of D allele and AT2R1 gene A1166S polymorphism C allele on renal function in patients with CAD and type II DM was proved.Посилання
Маньковский Б.Н. Сердечно-сосудистые забо¬ле¬ва¬ния у больных сахарным диабетом: что важно знать кардиологу, эндокринологу и неврологу / Б.Н. Ма¬ньковский, О.Н. Барна // Ліки України. – 2010. - №4 (140).
Реброва О.Ю. Статистический анализ меди¬цин¬ских данных. Применение пакета прикладных про¬грамм STATISTICA / О.Ю. Реброва – М: Ме¬диа¬Сфера, 2002. – 312 с.
Соколов Ю.Н. Коронарная болезнь и интер¬вен¬ционная кардиология / Ю.Н. Соколов, М.Ю. Соко¬лов, В.Г. Терентьев. – К.: Морион, 2011. – 767 с.
A genetic risk score is associated with incident cardiovascular disease and coronary artery calcium: the Framingham Heart Study / G. Thanassoulis, G.M. Peloso, M.J. Pencina [et al.] // Circ. Cardiovasc. Genet. – 2012. – Vol. 5, N 1. – P. 113-121. doi: 10.1161/CIRCGENETICS. 111.961342.
A reporting system on patients evaluated for coronary artery disease. Report of the Ad Hoc Committee for Grading of Coronary Artery Disease, Council on Cardiovascular Surgery, American Heart Association / W.G. Austen, J.E. Edwards, R.L. Frye [et al.] // Circu¬lation. – 1975. – Vol. 51. – P. 5-40.
Association of plasma nitric oxide concentration and endothelial nitric oxide synthase T-786C gene poly¬morphism in coronary artery disease. / S. Salimi, A. Nag¬havi, M. Firoozrai [et al.] // Pathophysiology. – 2012. - Vol. 19, N 3. – P. 157-162.
Ehret G.B. The Contribution of the Framingham Heart Study to Gene Identification for Cardiovascular Risk Factors and Coronary Heart Disease / G.B. Ehret // Glob. Heart. – 2013. – Vol. 8, N 1. – P. 59-65.
ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS) / A.L. Catapano, Z. Reiner, G. De Backer [et al.] // Athe¬rosclerosis. – 2011. – Vol. 217, N 1. – P. 3-46.
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts) / I. Graham, D. Atar, K. Borch-Johnsen [et al.] // Eur. J. Cardiovasc. Prev. Rehabil. - 2007. – Vol. 14, Suppl 2.- P. S1-113.
Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasoubd imaging / P. Pignoli, E. Tremoli, A. Poli [et al.] // Circulation. – 1986. – Vol. 74. – P. 1399-1406.
Genetic polymorphisms of angiotensin-2 type 1 receptor and angiotensinogen and risk of renal dysfun¬c¬tion and coronary heart disease in type 2 diabetes mellitus / J. Lin, F.B. Hu, L. Qi, G.C. Curhan / BMC Nephrol. – 2009. – Vol. 10. – P. 9. doi: 10.1186/1471-2369-10-9.
Lieb W. Genetics of coronary artery disease. / W. Lieb, R.S.Vasan. // Circulation. – 2013. – Vol. 128, N 10. – P. 1131-1138. doi: 10.1161/CIRCULATIONAHA.113. 005350.
Meta-analysis of the association between angiotensin II receptor, type 1 gene A1166C polym¬o¬r¬phism and coronary artery disease in Chinese populations / Y. Li, X. Li, N. Jia [et al.] // J. Renin Angiotensin Aldo¬sterone Syst. – 2013. – Vol. 14, N 1. – P. 82-90. doi: 10.1177/1470320312450599.
Qazi M.U. Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study./ M.U. Qazi , S. Malik // Glob. Heart. – 2013. – Vol. 8, N 1. – P. 43-48.
Raymond T. Management of the patient with dia¬betes and coronary artery disease: a contemporary review / T. Raymond, R. Raymond, A.M. Lincoff. // Future Car¬diol. – 2013. – Vol. 9, N 3. – P. 387-403. doi: 10.2217/ fca.13.22.
The ARTS study (Arterial Revascularization Therapies Study) / P.W. Serruys, F. Unger, B.A. van Hout [et al.] // Semin. Interv. Cardiol. – 1999. – Vol. 4. – P. 209-19.
Mankowski BN, Barna ON, Cardiovascular di¬sease in patients with diabetes mellitus: what is important to know a cardiologist, endocrinologist and a neurologist . Liky Ukraine. 2010;4(140).
Rebrova OY Statistical analysis of medical data. Application software package STATISTICA. M: Меdia¬Sphera 2002;312.
Sokolov YN, Sokolov MY, Terentev VG Co¬ro¬nary artery disease and interventional cardiology. K: Мо¬rion 2011;767.
Thanassoulis G, Peloso GM, Pencina MJ, Hof¬fmann U, Fox CS, Cupples LA, Levy D, D'Agostino RB, Hwang SJ, O'Donnell CJ. A genetic risk score is as¬sociated with incident cardiovascular disease and coro¬nary artery calcium: the Framingham Heart Study. Circ Cardiovasc Genet. 2012;5(1):113-21. doi: 10.1161/ CIRCGENETICS. 111.961342.
Austen WG, Edwards JE, Frye RL, Gensini GG, Gott VL, Griffith LS, McGoon DC, Murphy ML, Roe BB. A reporting system on patients evaluated for coro¬nary artery disease. Report of the AdHoc Committee for Grading of Coronary Artery Disease, Council on Cardio¬vascularSurgery, American Heart Association. Circu¬la¬tion. 1975;51(4):5-40.
Salimi S, Naghavi A, Firoozrai M, Zand H, Ta¬vilani H, Nakhaee A, Mohebbi A. Association of plasma nitric oxide concentration and endothelial nitric oxide synt¬hase T-786C gene polymorphism in coronary artery disease. Pathophysiology. 2012;19(3):157-62. doi: 10.1016/j.pathophys. 2012.04.003.
Ehret GB. The Contribution of the Framingham Heart Study to Gene Identification for Cardiovascular Risk Factors and Coronary Heart Disease. Glob Heart. 2013;8(1):59-65.
Catapano AL, Reiner Z, De Backer G, Graham I, Taskinen MR, Wiklund O, Agewall S, Alegria E, Chap¬man M, Durrington P, Erdine S, Halcox J, Hobbs R, Kjek¬shus J, Filardi PP, Riccardi G, Storey RF, Wood D. European Society of Cardiology (ESC); European Athe¬rosclerosis Society (EAS). ESC/EAS Guidelines for the management of dyslipidaemias The Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). Atherosclerosis. 2011;217(1):3-46.
Graham I, Atar D, Borch-Johnsen K, Boysen G, Burell G, Cifkova R, Dallongeville J, De Backer G, Eb¬rahim S, Gjelsvik B, Herrmann-Lingen C, Hoes A, Hum¬phries S, Knapton M, Perk J, Priori SG, Pyorala K, Reiner Z, Ruilope L, Sans-Menendez S, Op Reimer WS, Weis¬sberg P, Wood D, Yarnell J, Zamorano JL, Walma E, Fitzgerald T, Cooney MT, Dudina A, Vahanian A, Camm J, De Caterina R, Dean V, Dickstein K, Funck-Brentano C, Filippatos G, Hellemans I, Kristensen SD, McGregor K, Sechtem U, Silber S, Tendera M, Widimsky P, Za¬morano JL, Altiner A, Bonora E, Durrington PN, Fagard R, Giampaoli S, Hemingway H, Hakansson J, Kjeldsen SE, Larsen mL, Mancia G, Manolis AJ, Orth-Gomer K, Pedersen T, Rayner M, Ryden L, Sammut M, Schnei¬derman N, Stalenhoef AF, Tokgözoglu L, Wiklund O, Zampelas A. European Society of Cardiology (ESC); Euro¬pean Association for Cardiovascular Prevention and Rehabilitation (EACPR); Council on Cardiovascular Nursing; European Association for Study of Diabetes (EASD); International Diabetes Federation Europe (IDF-Europe); European Stroke Initiative (EUSI); Society of Behavioural Medicine (ISBM); European Society of Hypertension (ESH); WONCA Europe (European Society of General Practice/Family Medicine); European Heart Network (EHN); European Atherosclerosis Society (EAS). European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur J Cardiovasc Prev Rehabil. 2007;14( 2):1-113.
Pignoli P, Tremoli E, Poli A, Oreste P, Paoletti R. Intimal plus medial thickness of the arterial wall: a direct measurement with ultrasound imaging. Circulation. 1986;74(6):1399-406.
Lin J, Hu FB, Qi L, Curhan GC. Genetic poly¬morphisms of angiotensin-2 type 1 receptor and angio¬tensinogen and risk of renal dysfunction and coronary heart disease in type 2 diabetes mellitus. BMC Nephrol. 2009;10:9. doi: 10.1186/1471-2369-10-9.
Lieb W, Vasan RS. Genetics of coronary artery disease. Circulation. 2013;128(10):1131-8. doi: 10.1161/ CIRCULATIONAHA.113.005350.
Li Y, Li X, Jia N, Guo S, Chu S, Niu W. Meta-analysis of the association between angiotensin II recep¬tor, type 1 gene A1166C polymorphism and coronary ar¬tery disease in Chinese populations. J Renin Angiotensin Aldosterone Syst. 2013;14(1):82-90. doi: 10.1177/ 1470320312450599.
Qazi MU, Malik S. Diabetes and Cardiovascular Disease: Original Insights from the Framingham Heart Study. Glob Heart. 2013;8(1):43-48.
Raymond T, Raymond R, Lincoff AM. Mana¬gement of the patient with diabetes and coronary artery disease: a contemporary review. Future Cardiol. 2013;9(3):387-403. doi: 10.2217/fca.13.22.
Serruys PW, Unger F, van Hout BA, van den Brand MJ, van Herwerden LA, van Es GA, Bonnier JJ, Simon R, Cremer J, Colombo A, Santoli C, Vandor¬mael M, Marshall PR, Madonna O, Firth BG, Breeman A, Morel MA, Hugenholtz PG. The ARTS study (Arterial Revascularization Therapies Study). Semin Interv Car¬diol. 1999;4(4):209-19.
##submission.downloads##
Опубліковано
Як цитувати
Номер
Розділ
Ліцензія
Авторське право (c) 2017 Медичні перспективи
Ця робота ліцензується відповідно до Creative Commons Attribution-NonCommercial 4.0 International License.
Submitting manuscript to the journal "Medicni perspektivi" the author(s) agree with transferring copyright from the author(s) to publisher (including photos, figures, tables, etc.) editor, reproducing materials of the manuscript in the journal, Internet, translation into other languages, export and import of the issue with the author’s article, spreading without limitation of their period of validity both on the territory of Ukraine and other countries. This and other mutual duties of the author and all co-authors separately and editorial board are secured by written agreement by special form to use the article, the sample of which is presented on the site.
Author signs a written agreement and sends it to Editorial Board simultaneously with submission of the manuscript.
